What We're Reading: Page 256
Industry reads hand-picked by our editors
May 15, 2018
-
U.S. News & World Report
Will Alzheimer's research and treatment follow the AIDS model? Or malaria's?
-
Xconomy
Arch’s Bob Nelsen on big biotech and why pharma should be very afraid
-
The New York Times
My adventures with the trip doctors
May 14, 2018
-
The Washington Post
Viagra and many other drugs were discovered by chance. Now science is hoping to change that.
-
Nature
Blood, sweat and tears in biotech — the Theranos story
-
Financial Times
Pharma investors mobilise on reputational risk concerns
-
The Boston Globe
This Cambridge nonprofit is seeking every drug ever developed
May 11, 2018
-
The Wall Street Journal
Novartis CEO Calls Hiring of Trump Lawyer Michael Cohen a 'Mistake'
-
Vox
The blockbuster fight over this obscure federal program explains America’s drug prices
-
Bloomberg
Former biotech darlings Tesaro, Clovis pin hopes on 2018 rebound
-
CNN
An emotional call to eradicate ancient cousin of HIV
May 10, 2018
May 09, 2018
-
Financial Times
Banks scramble to assemble Asian biotech IPO resources
-
Nikkei Asian Review
Betting the pharma — Japan's misdirected M&A boom
-
The San Diego Union-Tribune
San Diego's Hybritech still influences local biotech, 40 years later
May 08, 2018
May 07, 2018
-
Financial Times
Pharma and healthcare companies brace for Trump shake-up
-
Haaretz
A strong quarter, but Teva’s not yet out of the woods
-
Genetic Engineering & Biotechnology News
25 up and coming gene therapies
-
Chemical & Engineering News
Controlling CAR-T: How scientists plan to make the engineered T cell therapy safer, and work for more cancers
Previous
